Loading: 100%
CELGENE CORP /DE/ logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 7,132 (as per Q1 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker CELGno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1780100120140160
datesClosing price (adj.)
13.10.2017136.46
11.10.2017139.56
04.10.2017146.52
27.09.2017142.97
20.09.2017144.24
13.09.2017141.26
06.09.2017140.16
30.08.2017134.34
23.08.2017129.19
16.08.2017131.26
09.08.2017135.57
02.08.2017134.85
26.07.2017137.75
19.07.2017135.00
12.07.2017133.56
05.07.2017133.20
27.06.2017130.93
20.06.2017126.22
13.06.2017119.62
06.06.2017116.88
30.05.2017115.13
23.05.2017117.31
16.05.2017119.36
09.05.2017120.10
02.05.2017123.82
25.04.2017125.52
18.04.2017123.01
11.04.2017125.06
04.04.2017124.77
28.03.2017124.43
21.03.2017123.82
14.03.2017124.68
07.03.2017122.08
28.02.2017123.51
21.02.2017119.44
14.02.2017117.02
07.02.2017116.26
31.01.2017116.15
24.01.2017112.45
17.01.2017114.95
10.01.2017119.98
03.01.2017118.75
27.12.2016117.92
19.12.2016115.73
12.12.2016113.22
05.12.2016116.56
28.11.2016120.30
21.11.2016124.16
14.11.2016120.68
07.11.2016107.49
31.10.2016102.18
24.10.201698.07
17.10.201699.64
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
136.46n/a
Market Capitalisation
in million USD
106,551n/a
Enterprise Value
in million USD
113,986n/a
Common Shares Outstanding
as per Apr 20, 2017
780,824,335n/a
Preferred Shares Outstanding
as per Apr 20, 2017
n/a
Average Basic Shares Outstanding
TTM
776,800,000n/a
Average Diluted Shares Outstanding
TTM
804,175,000n/a
Index Membership
n/a
Business Summary
Celgene Corp is a biotech company that discovers, develops, and commercializes therapies designed to treat cancer and immune-inflammatory related diseases. Its registered brands are Abraxane, Istodax, Otezla, Pomalyst, Revlimid, Thalomid, Vidaza.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 10,812n/a
Gross Profit 10,382n/a
Operating Income 3,246n/a
EBITDA 3,741n/a
Net Profit 2,131n/a
Balance Sheet
Cash and Cash Equivalents 6,869n/a
Receivables 1,586n/a
Total Current Assets 9,576n/a
PP&E 891n/a
Total Assets 26,754n/a
Accounts Payable 235n/a
Current Debt 501n/a
Total Current Liabilities 2,649n/a
Long-Term Debt 13,803n/a
Total Liabilities 21,103n/a
Total Equity 5,650n/a
Cash Flow
Depreciation & Amortisation 495n/a
Change in Working Capital -69n/a
Operating Cash Flow 3,692n/a
Net Change in PP&E and Intangibles -311n/a
Investing Cash Flow -659n/a
Dividends Paid 0n/a
Financing Cash Flow -3,511n/a
Total Change in Cash -494n/a
Free Cash Flow 2,874n/a
Profitability Ratios
Gross Margin 96.0%n/a
Operating Margin 30.0%n/a
Net Profit Margin 19.7%n/a
Return on Equity 37.7%n/a
Return on Assets 8.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 30.47n/a
EV/Sales 10.54n/a
Book to Market Value 0.05n/a
Other Ratios
Current Ratio 361.4%n/a
Liabilities to Equity Ratio 373.5%n/a
Debt to Assets Ratio 53.5%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
1,406
2,255
2,690
3,626
4,842
5,507
6,494
7,670
9,256
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-130
-258
-216
-307
-426
-299
-340
-386
-420
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
1,276
1,997
2,474
3,319
4,416
5,208
6,154
7,285
8,836
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-850
-1,721
-1,632
-2,282
-3,116
-3,292
-4,174
-4,717
-6,282
Selling, General & Administrative
-441
-686
-754
-951
-1,226
-1,374
-1,685
-2,028
-2,305
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-400
-931
-795
-1,128
-1,600
-1,724
-2,226
-2,431
-3,697
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
-9
-104
-83
-203
-289
-195
-263
-258
-279
Operating Income (Loss)
425
276
842
1,037
1,300
1,915
1,980
2,568
2,554
Non-Operating Income (Loss)
92
95
134
23
-23
-65
-144
-192
-231
Interest Expense, net
-11
-4
-2
-13
-43
-63
-92
-176
-311
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
110
85
77
45
26
15
22
28
31
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
-4
-10
-1
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-2
25
60
-9
-6
-17
-74
-44
48
Pretax Income (Loss), Adjusted
517
371
976
1,060
1,277
1,851
1,837
2,376
2,323
Abnormal Gains (Losses)
0
-1,740
0
-47
142
-169
-171
-49
-300
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
517
-1,369
976
1,013
1,420
1,682
1,665
2,327
2,024
Income Tax (Expense) Benefit, net
-291
-165
-199
-132
-102
-225
-216
-328
-422
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
226
-1,534
777
880
1,317
1,456
1,450
2,000
1,602
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
226
-1,534
777
880
1,317
1,456
1,450
2,000
1,602
Minority Interest
0
0
0
0
1
0
0
0
0
Net Income
226
-1,534
777
881
1,318
1,456
1,450
2,000
1,602
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
226
-1,534
777
881
1,318
1,456
1,450
2,000
1,602
Remarks
restated on Feb 18, 2010 n/a
calculated values,
restated on Mar 1, 2011 n/a
calculated values,
restated on Feb 22, 2012 n/a
calculated values,
restated on Feb 15, 2013 n/a
calculated values,
restated on Feb 13, 2014 n/a
calculated values,
restated on Feb 20, 2015 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Feb 10, 2017 n/a
calculated values,
restated on Feb 10, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
2,222
2,997
2,601
2,648
3,900
5,687
7,547
6,552
Cash & Cash Equivalents
n/a
1,092
1,102
1,351
1,859
2,090
3,234
4,122
4,880
Short Term Investments
n/a
1,130
1,895
1,250
789
1,810
2,453
3,425
1,672
Accounts & Notes Receivable
n/a
312
439
706
946
961
1,061
1,167
1,421
Accounts Receivable, Net
n/a
312
439
706
946
961
1,061
1,167
1,421
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
100
101
260
190
260
340
393
443
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
207
309
775
570
413
462
606
985
Prepaid Expenses
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
349
58
0
0
0
0
Deferred Tax Assets
n/a
16
50
152
117
93
25
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
190
259
275
395
320
436
606
985
Total Current Assets
n/a
2,841
3,845
4,343
4,353
5,534
7,551
9,713
9,401
Property, Plant & Equipment, Net
n/a
249
298
510
506
578
593
643
814
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
23
0
0
0
0
0
Long Term Investments
n/a
0
0
23
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
1,355
1,247
5,301
5,147
5,622
5,234
6,985
16,749
Intangible Assets
n/a
435
350
3,248
2,845
3,100
2,840
4,068
10,858
Goodwill
n/a
589
578
1,896
1,887
2,043
2,041
2,191
4,879
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
18
21
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
313
298
156
415
479
353
726
1,012
Total Noncurrent Assets
n/a
1,604
1,545
5,834
5,653
6,201
5,828
7,628
17,564
Total Assets
n/a
4,445
5,389
10,177
10,006
11,734
13,378
17,340
26,964
Liabilities and owners' equity
Payables & Accruals
n/a
411 411141000
399 399111000
698 698224000
853 853274000
933 933100000
1,173 1173300000
1,202 1202000000
1,908 1908300000
Accounts Payable
n/a
54 53859000
37 36629000
94 94465000
122 121525000
146 145600000
156 156200000
198 198200000
241 240800000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
357 357282000
362 362482000
604 603759000
732 731749000
788 787500000
1,017 1017100000
1,004 1003800000
1,668 1667500000
Short Term Debt
n/a
0 0
0 0
0 0
527 526684000
309 308500000
545 544800000
606 605900000
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
116 116107000
96 95594000
372 372158000
160 160014000
449 448600000
227 227400000
304 304300000
61 60600000
Deferred Revenue
n/a
1 1419000
2 1827000
16 16362000
14 14346000
17 17300000
28 27700000
29 28500000
61 60600000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
47 46582000
7 7244000
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
115 114688000
94 93767000
309 309214000
138 138424000
431 431300000
200 199700000
276 275800000
0 0
Total Current Liabilities
n/a
527 527248000
495 494705000
1,070 1070382000
1,540 1539972000
1,690 1690200000
1,946 1945500000
2,112 2112200000
1,969 1968900000
Long Term Debt
n/a
0 0
0 0
1,248 1247584000
1,276 1275585000
2,771 2771300000
4,197 4196500000
6,266 6265700000
14,161 14161400000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
427 426694000
500 500000000
1,864 1863724000
1,678 1677626000
1,578 1578300000
1,646 1646300000
2,437 2437400000
4,915 4915100000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
3 3127000
7 6527000
13 12785000
13 12623000
16 16200000
24 23700000
28 27800000
30 30000000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
424 423567000
493 493473000
1,851 1850939000
1,665 1665003000
1,562 1562100000
1,623 1622600000
2,410 2409600000
4,885 4885100000
Total Noncurrent Liabilities
n/a
427 426694000
500 500000000
3,111 3111308000
2,953 2953211000
4,350 4349600000
5,843 5842800000
8,703 8703100000
19,077 19076500000
Total Liabilities
n/a
954 953942000
995 994705000
4,182 4181690000
4,493 4493183000
6,040 6039800000
7,788 7788300000
10,815 10815300000
21,045 21045400000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
5,185 5185030000
5,479 5478798000
6,355 6355062000
6,769 6769353000
7,545 7544800000
8,686 8685500000
9,836 9836400000
11,129 11128700000
Common Stock
n/a
5 4633000
5 4676000
5 4822000
5 4874000
5 5000000
9 9100000
9 9200000
9 9400000
Additional Paid in Capital
n/a
5,180 5180397000
5,474 5474122000
6,350 6350240000
6,764 6764479000
7,540 7539800000
8,676 8676400000
9,827 9827200000
11,119 11119300000
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-157 -157165000
-363 -362521000
-546 -545588000
-2,761 -2760705000
-4,823 -4823200000
-7,662 -7662100000
-10,699 -10698800000
-14,052 -14051800000
Retained Earnings
n/a
-1,409 -1408993000
-632 -632246000
248 248266000
1,566 1566416000
3,023 3022600000
4,473 4472500000
6,472 6472400000
8,074 8074400000
Other Equity
n/a
-128 -127544000
-89 -89425000
-74 -73767000
-62 -62337000
-50 -49700000
94 94000000
915 914800000
768 767700000
Equity Before Minority Interest
n/a
3,491 3491328000
4,395 4394606000
5,984 5983973000
5,513 5512727000
5,695 5694500000
5,590 5589900000
6,525 6524800000
5,919 5919000000
Minority Interest
n/a
0 0
0 0
11 11499000
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
3,491 3491328000
4,395 4394606000
5,995 5995472000
5,513 5512727000
5,695 5694500000
5,590 5589900000
6,525 6524800000
5,919 5919000000
Total Liabilities & Equity
n/a
4,445 4445270000
5,389 5389311000
10,177 10177162000
10,006 10005910000
11,734 11734300000
13,378 13378200000
17,340 17340100000
26,964 26964400000
Remarks restated on n/a restated on Feb 18, 2010 n/a restated on Mar 1, 2011 n/a restated on Feb 22, 2012 n/a restated on Feb 15, 2013 n/a restated on Feb 13, 2014 n/a restated on Feb 20, 2015 n/a restated on Feb 11, 2016 n/a restated on Oct 27, 2016 n/a
Cash Flow StatementCF data quality: 97% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
226
-1,534
777
880
1,317
1,456
1,450
2,000
1,602
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
32
138
126
259
363
284
374
374
409
Non-Cash Items
73
1,788
138
150
70
669
323
304
523
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
146
-210
-131
-108
26
-390
79
129
-50
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
478
182
910
1,182
1,776
2,019
2,226
2,806
2,484
Change in Fixed Assets & Intangibles
-64
-77
-93
-99
-132
-160
-120
-150
-286
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-917
303
-762
646
516
-1,055
-388
-553
1,730
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-2
-760
-4
-2,652
0
-352
0
-710
-7,695
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
-8
12
3
-2
-6
14
-21
-25
-7
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-990
-522
-856
-2,107
378
-1,554
-529
-1,438
-6,259
Dividends Paid
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
1,237
526
1,269
1,714
2,025
7,298
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
-209
-183
-2,189
-2,044
-2,765
-2,975
-3,257
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
288
282
148
123
41
526
497
532
544
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
288
282
-62
1,177
-1,622
-249
-554
-417
4,585
Net Cash Before Disc. Operations and FX
-225
-58
-8
251
532
216
1,144
951
809
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-225
-58
-8
251
532
216
1,144
951
809
Effect of Foreign Exchange Rates
4
-67
18
-2
-23
15
0
-64
-51
Net Changes in Cash
-221
-126
10
249
508
231
1,144
887
759
Remarks
restated on Feb 18, 2010 n/a
calculated values,
restated on Mar 1, 2011 n/a
calculated values,
restated on Feb 22, 2012 n/a
calculated values,
restated on Feb 15, 2013 n/a
calculated values,
restated on Feb 13, 2014 n/a
calculated values,
restated on Feb 20, 2015 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo